Long-term experience with intraoperative electron radiation therapy boost in extremity sarcoma

J Surg Oncol. 2022 Dec;126(7):1279-1287. doi: 10.1002/jso.27024. Epub 2022 Jul 20.

Abstract

Background: In patients with extremity soft tissue sarcoma (eSTS), we describe outcomes of preoperative external beam radiation therapy (EBRT), limb-sparing surgery (LSS), and intraoperative electron radiation therapy (IOERT).

Methods: One hundred and eighteen patients with eSTS treated between October 17, 2002 and July 28, 2021 were identified. EBRT was delivered preoperatively followed by LSS and IOERT.

Results: The median follow-up was 24.9 months. The presentation was primary in 102 (94%) patients and recurrent in 6 (6%) patients. Tumor location was lower extremity in 82 (76%) patients and upper extremity in 26 (24%) patients. Stage distribution was as follows: 3 (3%) IA, 24 (22%) IB, 31 (29%) II, 24 (22%) IIIA, and 25 (23%) IIIB. Final surgical margins were negative in 96 (89%) patients. The 5-year local control, failure-free survival, and overall survival were 94%, 75%, and 64%, respectively. Univariate analysis identified age >50, lower extremity, and higher grade as significant negative prognostic factors for overall survival. Grade 3 fracture or osteoradionecrosis requiring surgical fixation, neuropathy, and lymphedema occurred in 7 (6%), 1 (1%), and 0 patients, respectively.

Conclusions: This study represents one of the largest series using preoperative EBRT, LSS, and IOERT for eSTS, with high local control and a low rate of late severe toxicity.

Keywords: extremity soft tissue sarcoma; intraoperative electron radiation therapy; radiation therapy.

MeSH terms

  • Combined Modality Therapy
  • Electrons
  • Humans
  • Lower Extremity / pathology
  • Neoplasm Recurrence, Local / surgery
  • Sarcoma* / pathology
  • Sarcoma* / radiotherapy
  • Sarcoma* / surgery
  • Soft Tissue Neoplasms* / pathology
  • Soft Tissue Neoplasms* / radiotherapy
  • Soft Tissue Neoplasms* / surgery